Volume 79, Issue 11, Pages (June 2011)

Slides:



Advertisements
Similar presentations
Plasma creatinine determination in mice and rats: An enzymatic method compares favorably with a high-performance liquid chromatography assay A. Keppler,
Advertisements

Volume 67, Issue 2, Pages (February 2005)
Volume 64, Issue 4, Pages (October 2003)
Volume 71, Issue 1, Pages (January 2007)
Volume 64, Issue 6, Pages (December 2003)
From: Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate.
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
Volume 69, Issue 7, Pages (April 2006)
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Volume 67, Issue 5, Pages (May 2005)
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Determinants of phosphorus mobilization during hemodialysis
Prehypertension and chronic kidney disease: the ox or the plow?
Volume 67, Issue 2, Pages (February 2005)
John P. Middleton, Patrick H. Pun  Kidney International 
Calcium phosphate particulates increase friction in the rat knee joint
Better nephrology for mice—and man
Volume 81, Issue 1, Pages (January 2012)
Volume 77, Issue 8, Pages (April 2010)
The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli  Richard J. Glassock, Andrew D. Rule  Kidney.
Volume 78, Issue 12, Pages (December 2010)
Volume 71, Issue 1, Pages (January 2007)
Volume 77, Issue 1, Pages 5-6 (January 2010)
How to interpret the eGFR in patients with small body surface area
Comorbidity and confounding in end-stage renal disease
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 67, Issue 2, Pages (February 2005)
Predicting an allograft's fate
U-shaped effect of eGFR and mortality
Volume 79, Issue 2, Pages (January 2011)
Volume 60, Issue 4, Pages (October 2001)
Volume 81, Issue 5, Pages (March 2012)
Volume 70, Issue 1, Pages (July 2006)
Impact of gender on the renal response to angiotensin II
Online feedback–controlled renal constant infusion clearances in rats
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate  N. Takahashi, G. Boysen, F.
Volume 69, Issue 12, Pages (June 2006)
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Volume 85, Issue 5, Pages (May 2014)
Volume 84, Issue 5, Pages (November 2013)
Nephrology Crossword: Peritoneal Dialysis
Angiotensin II production and distribution in the kidney: I
Angiotensin II production and distribution in the kidney – II
Nephrology Crossword: Glomerulonephritis
Volume 64, Issue 6, Pages (December 2003)
Renovascular adaptive changes in chronic hypoxic polycythemia
Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria  Bernd Hoppe, Markus J. Kemper, Arend.
Volume 68, Issue 4, Pages (October 2005)
Volume 80, Issue 3, Pages (August 2011)
Volume 76, Issue 1, Pages 6-7 (July 2009)
Volume 76, Issue 7, Pages (October 2009)
Noninvasive transcutaneous determination of access blood flow rate
Volume 76, Issue 6, Pages (September 2009)
Volume 80, Issue 10, Pages (November 2011)
Cellular contributions to glomerular size-selectivity
Volume 80, Issue 10, Pages (November 2011)
Volume 76, Issue 1, Pages 8-10 (July 2009)
Volume 64, Issue 2, Pages (August 2003)
Volume 65, Issue 1, Pages (January 2004)
Volume 58, Issue 2, Pages (August 2000)
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Thomas C. Dowling, Reginald F. Frye, Donald S. Fraley, Gary R. Matzke 
Volume 61, Issue 1, Pages (January 2002)
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Taqumpay Esmiraldo Tigcal Sacamay, W. Kline Bolton 
Volume 75, Issue 8, Pages (April 2009)
Volume 80, Issue 4, Pages (August 2011)
The Ebf1 knockout mouse and glomerular maturation
Presentation transcript:

Volume 79, Issue 11, Pages 1254-1258 (June 2011) Transcutaneous assessment of renal function in conscious rats with a device for measuring FITC-sinistrin disappearance curves  Daniel Schock-Kusch, Qing Xie, Yury Shulhevich, Juergen Hesser, Dzmitry Stsepankou, Maliha Sadick, Stefan Koenig, Friederike Hoecklin, Johannes Pill, Norbert Gretz  Kidney International  Volume 79, Issue 11, Pages 1254-1258 (June 2011) DOI: 10.1038/ki.2011.31 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 New device. Optical part of the new device for transcutaneous measurement (a) and a schematic drawing of its building blocks (b). LED, light-emitting diode; RFID, radio-frequency identification. Kidney International 2011 79, 1254-1258DOI: (10.1038/ki.2011.31) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Excretion kinetics. Example of a transcutaneously (a) measured disappearance curve and its counterpart measured in plasma enzymatically as well as fluorometrically (b) after intravenous injection of 63mg per 100g body weight fluorescein isothiocyanate (FITC)-sinistrin dissolved in phosphate-buffered saline (400mg/ml). (a) Shows a typical example of a transcutaneously measured FITC-sinistrin excretion kinetic and the fitted bi-exponential regression curve. The background signal of the measurement of 166.6 AU is plotted as dashed line. (b) Gives the corresponding excretion kinetics measured in plasma and the exponential regression curve fitted to the second part of the curve (black data points, solid line represents fluorometric measurement; black crosses, dashed line represents enzymatic measurement). Open circles (fluorometric) and open squares (enzymatic) indicate the initial fast decrease in concentration in plasma caused by the combination of diffusion into the interstitial space and the renal clearance of FITC-sinistrin. Kidney International 2011 79, 1254-1258DOI: (10.1038/ki.2011.31) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Method comparison for determination of half-life and glomerular filtration rate (GFR) in rats after intravenous injection of FITC-sinistrin measured transcutaneously as well as enzymatically in plasma. Scatter plot of half-life (r2=0.57 for y(x)=ax regression function) (a) and calculated GFR (r2=0.59 for y(x)=ax regression function) (b) with lines of identity (dashed), are depicted (n=18). Bland–Altman plot (c)20,21 shows a mean difference (bias) of 0.01ml/min per 100g b.w. and a 95% limit of agreement of -0.30 to 0.33ml/min per 100g b.w. Kidney International 2011 79, 1254-1258DOI: (10.1038/ki.2011.31) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Scatter plot of transcutaneously measured emission signal and fluorometrically measured fluorescein isothiocyanate (FITC)-sinistrin concentration in plasma. The plot illustrates that a transcutaneous measurement is possible down to a plasma concentration of about 0.07mg/ml. Kidney International 2011 79, 1254-1258DOI: (10.1038/ki.2011.31) Copyright © 2011 International Society of Nephrology Terms and Conditions